Skip to main content
. 2013 Feb 21;3:1317. doi: 10.1038/srep01317

Figure 6. Proposed model for TARS angiogenic activity.

Figure 6

VEGF or TNF-α secretion by hypoxic or immune cells (a) leads to receptor-activated stimulation of TARS secretion (b). Secreted TARS has autocrine and possibly paracrine functions (c) that promote angiogenic signaling (i.e. migration) (d). BC194 binds and inactivates TARS, preventing its angiogenic function.